BioArctic Logo

BioArctic

Develops treatments and diagnostics for neurodegenerative disorders like Alzheimer's and Parkinson's.

BIOA | ST

Overview

Corporate Details

ISIN(s):
SE0010323303 (+1 more)
LEI:
549300Y0OI2WVUNHLC33
Country:
Sweden
Address:
Warfvinges väg 35, 112 51 Stockholm

Description

BioArctic is a Swedish research-intensive biopharmaceutical company focused on developing novel, disease-modifying treatments and diagnostics for neurodegenerative disorders. The company's core mission is to address the underlying causes of diseases such as Alzheimer's and Parkinson's. Its research is centered on developing innovative drugs and antibodies that target the root mechanisms of nerve cell damage and misfolded proteins, aiming to provide effective solutions for significant unmet medical needs within the central nervous system.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-07-10 08:00 Swedish 776.3 KB
2020-07-10 08:00 English 761.1 KB
2020-07-01 08:30
Inbjudan till presentation av BioArctics delårsrapport för perioden januari – j…
Swedish 187.2 KB
2020-07-01 08:30
Invitation to presentation of BioArctic’s Interim Report for the period January…
English 178.4 KB
2020-05-26 15:30
Styrelse och ledning i BioArctic ökar sitt ägande
Swedish 211.3 KB
2020-05-26 15:30
Members of BioArctic’s Board of Directors and management increase their shareho…
English 214.1 KB
2020-05-07 18:45
Report from Annual General Meeting in BioArctic (publ)
English 193.4 KB
2020-05-07 18:45
Kommuniké från årsstämman i BioArctic (publ)
Swedish 192.8 KB
2020-04-22 08:00 Swedish 757.4 KB
2020-04-22 08:00 English 758.0 KB
2020-04-15 08:30
Invitation to presentation of BioArctic’s Interim Report for the first quarter …
English 188.5 KB
2020-04-15 08:30
Inbjudan till presentation av BioArctics delårsrapport för första kvartalet jan…
Swedish 189.1 KB
2020-04-07 08:00
Kallelse till årsstämma i BioArctic AB (publ)
Swedish 185.2 KB
2020-04-07 08:00
Notice of Annual General Meeting in BioArctic AB (Publ)
English 179.1 KB
2020-04-02 08:00
BioArctic publishes the Annual Report for 2019
English 181.0 KB

Automate Your Workflow. Get a real-time feed of all BioArctic filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioArctic

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioArctic via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-13 Gunilla Osswald Other Sell 40,000 8,821,200.00 SEK
2025-02-13 Gunilla Osswald Other Other 40,000 3,344,000.00 SEK
2025-02-13 Sten Mikael Moge Other Sell 6,000 1,323,180.00 SEK
2025-02-13 Sten Mikael Moge Other Other 6,000 501,600.00 SEK
2025-02-13 Johanna Margareta Fälting Other Sell 1,500 330,795.00 SEK
2025-02-13 Johanna Margareta Fälting Other Other 2,500 209,000.00 SEK
2025-02-13 Johanna Margareta Fälting Other Other 1,500 125,400.00 SEK
2025-01-10 Mikael Smedeby Other Buy 730 148,920.00 SEK
2024-12-19 Oskar Bosson Other Sell 2,000 446,000.00 SEK
2024-12-19 Oskar Bosson Other Sell 871 195,626.60 SEK

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapies for oncology & ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland
ACHI
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden
ACTI
Adagene Inc. Logo
Develops novel antibody-based immunotherapies for cancer using an AI-driven discovery platform.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.